Currently this market is a monopoly for TPA by Genetech. The catheter clearance market in the U.S. is estimated currently at $350M+. It will likely take 3 years to bring Kinlytic to market. Estimated fair value of Kinlytic is roughly $95M. Current market cap on Microbix is $38M. This is an FDA approved drug. They have to find a manufacturer, then show that the newly manufactured drug is similar/equivalent to the previous product. Sequel Pharma will be paying the estimated $35M for this process. Microbix/Sequel have been in discussions with the FDA about how to proceed, and based on these discussions, Sequel has made the commitment to fully find this and proceed.
Market Data 
Markets 
AI
